 Concomitant chemotherapy split-course radiation cure preservation speech swallowing head neck cancer ability simultaneous cisplatin radiation surgery radiation advanced head neck cancer phase II study subgroup patients primary disease hemiglossectomy laryngectomy control Patients stage IV stage III disease tongue hypopharynx larynx primaries treatment concurrent cisplatin split-course radiation week total cycles weeks median follow-up years patients preservation speech and/or function Median survival months patients alive disease free dead cancer dead causes overall failure rate Advanced-stage presence nodal disease cycles chemotherapy failure rates program concomitant cisplatin radiation control rates competitive surgery radiation appropriate definitive testing randomized trial